Jiangsu Hengrui Medicine Co., Ltd.

SSE:600276.SS

51.84 (CNY) • At close June 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Revenue 27,984.60522,819.78521,275.27125,905.52627,734.59923,288.57717,417.90113,835.62911,093.7249,315.967,452.2536,203.0745,435.0684,550.3923,744.1063,028.9612,392.5611,959.661,422.4571,179.261,145.1441,050.352756.025634.269484.707413.93363.792303.571
Cost of Revenue 3,848.1773,525.2483,486.6393,741.7993,348.692,912.9442,334.5681,849.8771,434.6311,371.671,313.2161,158.082870.397784.143605.503523.852400.873330.374266.339229.909286.319348.194278.597255.392226.709216.244205.613180.389
Gross Profit 24,136.42819,294.53717,788.63222,163.72824,385.90920,375.63315,083.33311,985.7529,659.0937,944.296,139.0375,044.9934,564.6713,766.2493,138.6032,505.1091,991.6881,629.2861,156.118949.351858.825702.158477.429378.877257.998197.686158.179123.182
Gross Profit Ratio 0.8620.8460.8360.8560.8790.8750.8660.8660.8710.8530.8240.8130.840.8280.8380.8270.8320.8310.8130.8050.750.6680.6310.5970.5320.4780.4350.406
Reseach & Development Expenses 6,582.9164,953.8874,886.5535,943.3064,988.9583,896.3362,670.4811,759.1311,184.348891.674651.984563.129535.01465.17600000000000000
General & Administrative Expenses 1,665.612,286.2031,750.7832,055.1732,227.3431,550.09997.2431,124.433936.491782.568689.9641,155.604314.134282.663621.392435.723341.966406.23300.882239.663226.649198.347117.266107.04465.03857.80241.80732.18
Selling & Marketing Expenses 5,555.0317,577.1767,347.8939,383.7089,802.5248,524.9686,464.4915,188.9234,351.6213,524.9792,844.2432,354.792,339.6351,912.411,604.6791,345.505965.436798.095562.558475.995430.682339.859234.069168.59111.79566.93155.58447.033
SG&A 7,220.6419,978.3839,098.67611,438.88112,029.86710,075.0577,461.7346,313.3565,288.1124,307.5473,534.2073,510.3932,653.7692,195.0732,226.0711,781.2281,307.4021,204.325863.44715.659657.331538.206351.335275.634176.833124.73397.39179.212
Other Expenses 2,842.24-584.855458.682697.903888.686717.719-97.574-48.632-9.3329.3827.5231.43446.56432.65114.9938.96720.3143.8170.5446.1182.70314.5412.1279.68912.590.6834.11613.207
Operating Expenses 16,645.79614,384.63214,443.91118,080.0917,907.51114,689.11310,835.0298,239.8326,820.6335,524.0484,440.4843,616.6483,326.6132,732.7962,282.1941,826.4471,345.1081,235.492886.049734.843674.885551.592360.618283.441181.827128.907100.51481.527
Operating Income 7,490.6324,909.9054,111.964,664.8167,007.0726,149.6794,596.6543,807.8213,024.3342,558.8711,772.4481,451.0741,300.2041,032.395845.215771.719449.706507.643289.75225.902178.179140.141110.59391.2373.35262.56148.97632.517
Operating Income Ratio 0.2680.2150.1930.180.2530.2640.2640.2750.2730.2750.2380.2340.2390.2270.2260.2550.1880.2590.2040.1920.1560.1330.1460.1440.1510.1510.1350.107
Total Other Income Expenses Net -320.942-242.795-143.468-198.507-111.592-93.918-97.574-48.632-9.8733.127.20327.45846.29432.65114.79292.218-143.739140.424-0.455-5.198-11.19110.554-0.0846.4368.5360.153.15811.994
Income Before Tax 7,169.694,667.113,968.4924,466.3096,895.486,055.7624,499.083,759.1893,013.1852,561.971,799.6511,478.5321,346.4981,065.046860.207780.686470.02511.46289.295220.704172.657150.695110.50997.66581.88762.71152.13444.512
Income Before Tax Ratio 0.2560.2050.1870.1720.2490.260.2580.2720.2720.2750.2410.2380.2480.2340.230.2580.1960.2610.2030.1870.1510.1430.1460.1540.1690.1520.1430.147
Income Tax Expense 832.695389.289153.421-17.718586.587729.31437.895466.235378.99338.001226.722186.479195.091124.64104.77287.38634.42692.92884.39360.63151.34258.4931.23716.26216.3511.0618.4943.382
Net Income 6,336.5274,302.4363,906.3754,530.2186,328.3835,328.0284,065.613,216.6482,588.9522,171.5721,515.5691,238.1111,077.385876.611724.173665.731422.947412.921206.648162.222122.6294.5278.95481.15565.27151.33243.2341.071
Net Income Ratio 0.2260.1890.1840.1750.2280.2290.2330.2320.2330.2330.2030.20.1980.1930.1930.220.1770.2110.1450.1380.1070.090.1040.1280.1350.1240.1190.135
EPS 10.680.610.7110.840.640.50.410.340.240.20.170.140.120.110.0680.0660.0330.0210.0160.0120.010.010.010.0150.0130.012
EPS Diluted 10.680.610.7110.840.630.50.410.340.240.20.170.140.120.110.0680.0660.0330.0210.0160.0120.010.010.010.0150.0130.012
EBITDA 7,951.2795,540.3984,683.2375,021.077,377.2596,681.1654,886.7664,063.1013,270.4212,635.4951,904.8831,596.5141,479.6371,164.515931.336844.962706.821449.845350.89280.284230.812207.2145.527127.719104.20582.10257.66541.655
EBITDA Ratio 0.2840.2430.220.1940.2660.2870.2810.2940.2950.2830.2560.2570.2720.2560.2490.2790.2950.230.2470.2380.2020.1970.1920.2010.2150.1980.1590.137